Carlos Stahlhut
About Carlos Stahlhut
Carlos Stahlhut is a Principal Scientist at BridgeBio, with a strong background in biochemistry and genetics. He has extensive experience in hematological oncology and has worked at notable institutions including Yale University and REVOLUTION Medicines.
Current Role at BridgeBio
Carlos Stahlhut serves as a Principal Scientist at BridgeBio, a position he has held since 2021. He is based in South San Francisco, California. In this role, he focuses on advancing research initiatives within the organization, contributing his expertise in hematological oncology and molecular biology.
Previous Experience at REVOLUTION Medicines
Carlos Stahlhut worked at REVOLUTION Medicines from 2017 to 2021, where he held the positions of Scientist II and Senior Scientist. During his tenure, he was involved in projects related to oncology drug development, leveraging his extensive background in experimental techniques and genomic analysis.
Educational Background in Biochemistry and Genetics
Carlos Stahlhut earned his Bachelor of Science in Biochemistry from McGill University, studying from 2001 to 2005. He later pursued a Ph.D. in Genetics at Yale University, where he studied from 2005 to 2011. His educational background provides a strong foundation for his research in molecular biology and oncology.
Research Experience at Yale University
At Yale University, Carlos Stahlhut held multiple roles, including Ph.D. Candidate and Postdoctoral Associate. His research spanned from 2006 to 2014, during which he focused on various aspects of genetics and cell biology. This experience contributed to his expertise in signal transduction and cell biology.
Expertise in Experimental Techniques
Carlos Stahlhut possesses extensive expertise in both in vivo and in vitro experimental techniques. His skills include cell-based assays and animal models, as well as proficiency in independent experimental design, execution, analysis, and interpretation. This expertise supports his work in hematological oncology.